OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Importance of the second extracellular loop for melatonin MT1 receptor function and absence of melatonin binding in GPR50
Nathalie Clément, Nicolas Renault, Jean‐Luc Guillaume, et al.
British Journal of Pharmacology (2017) Vol. 175, Iss. 16, pp. 3281-3297
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Structural basis of ligand recognition at the human MT1 melatonin receptor
Benjamin Stauch, Linda C. Johansson, John D. McCorvy, et al.
Nature (2019) Vol. 569, Iss. 7755, pp. 284-288
Open Access | Times Cited: 169

Melatonin Target Proteins: Too Many or Not Enough?
Lei Liu, Nedjma Labani, Erika Cecon, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 92

Melatonin receptor structure and signaling
Hiroyuki Okamoto, Erika Cecon, Osamu Nureki, et al.
Journal of Pineal Research (2024) Vol. 76, Iss. 3
Open Access | Times Cited: 10

Cryo-EM structure of the human MT1–Gi signaling complex
Hiroyuki Okamoto, Hirotake Miyauchi, Asuka Inoue, et al.
Nature Structural & Molecular Biology (2021) Vol. 28, Iss. 8, pp. 694-701
Closed Access | Times Cited: 55

Type 2 diabetes–associated variants of the MT 2 melatonin receptor affect distinct modes of signaling
Angeliki Karamitri, Bianca Plouffe, Amélie Bonnefond, et al.
Science Signaling (2018) Vol. 11, Iss. 545
Open Access | Times Cited: 57

Melatonin Receptor Signaling: Impact of Receptor Oligomerization on Receptor Function
Atsuro Oishi, Erika Cecon, Ralf Jockers
International review of cell and molecular biology (2018), pp. 59-77
Closed Access | Times Cited: 51

Melatonin MT1 receptor as a novel target in neuropsychopharmacology: MT1 ligands, pathophysiological and therapeutic implications, and perspectives
Stefano Comai, Martha López-Canul, Danilo De Gregorio, et al.
Pharmacological Research (2019) Vol. 144, pp. 343-356
Closed Access | Times Cited: 50

Structural insights into melatonin receptors
Benjamin Stauch, Linda C. Johansson, Vadim Cherezov
FEBS Journal (2019) Vol. 287, Iss. 8, pp. 1496-1510
Open Access | Times Cited: 50

Melatonin receptor structures shed new light on melatonin research
Erika Cecon, Lei Liu, Ralf Jockers
Journal of Pineal Research (2019) Vol. 67, Iss. 4
Closed Access | Times Cited: 49

Design, Synthesis, In Silico Studies and In Vitro Evaluation of New Indole- and/or Donepezil-like Hybrids as Multitarget-Directed Agents for Alzheimer’s Disease
Violina T. Angelova, B. Georgiev, Tania Pencheva, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1194-1194
Open Access | Times Cited: 13

Characterization of the Mel1c melatoninergic receptor in platypus (Ornithorhynchus anatinus)
Célia Gautier, Sophie‐Pénélope Guenin, Isabelle Riest‐Fery, et al.
PLoS ONE (2018) Vol. 13, Iss. 3, pp. e0191904-e0191904
Open Access | Times Cited: 28

Molecular Characterization and Pharmacology of Melatonin Receptors in Animals
Erika Cecon, Jean A. Boutin, Ralf Jockers
Receptors (2023) Vol. 2, Iss. 2, pp. 127-147
Open Access | Times Cited: 9

Detection of recombinant and endogenous mouse melatonin receptors by monoclonal antibodies targeting the C‐terminal domain
Erika Cecon, Anna Ivanova, Marine Luka, et al.
Journal of Pineal Research (2018) Vol. 66, Iss. 2
Closed Access | Times Cited: 21

ERNEST COST action overview on the (patho)physiology of GPCRs and orphan GPCRs in the nervous system
Necla Birgül İyison, Clauda Abboud, Dayana Abboud, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 2

Recent developments in research of melatonin and its potential therapeutic applications
S. Clare Stanford
British Journal of Pharmacology (2018) Vol. 175, Iss. 16, pp. 3187-3189
Open Access | Times Cited: 19

In silico drug discovery of melatonin receptor ligands with therapeutic potential
Gian Marco Elisi, Laura Scalvini, Alessio Lodola, et al.
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 4, pp. 343-354
Closed Access | Times Cited: 8

Phylogenetic Reclassification of Vertebrate Melatonin Receptors To Include Mel1d
Elsa Denker, Lars O.E. Ebbesson, David G. Hazlerigg, et al.
G3 Genes Genomes Genetics (2019) Vol. 9, Iss. 10, pp. 3225-3238
Open Access | Times Cited: 13

Why Are We Still Cloning Melatonin Receptors? A Commentary
Célia Gautier, Isabelle Théret, Giulia Lizzo, et al.
Methods in molecular biology (2022), pp. 267-281
Closed Access | Times Cited: 8

Hamster Melatonin Receptors: Cloning and Binding Characterization of MT1 and Attempt to Clone MT2
Célia Gautier, Emilie Dufour, Clémence Dupré, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 7, pp. 1957-1957
Open Access | Times Cited: 10

Monoamines and their Derivatives on GPCRs: Potential Therapy for Alzheimer’s Disease
Eunice D. Farfán‐García, Ricardo Márquez-Gómez, Mónica Barrón‐González, et al.
Current Alzheimer Research (2019) Vol. 16, Iss. 10, pp. 871-894
Closed Access | Times Cited: 9

Identification of Key Regions Mediating Human Melatonin Type 1 Receptor Functional Selectivity Revealed by Natural Variants
Alan Hégron, Eunna Huh, Xavier Deupí, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 5, pp. 1614-1627
Open Access | Times Cited: 7

Phylogenetic reclassification of vertebrate melatonin receptors to include Mel1d
Elsa Denker, Lars O.E. Ebbesson, David G. Hazlerigg, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top